• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wilms 瘤 1 相关蛋白在弥漫性大 B 细胞淋巴瘤中发挥侵袭性作用,并通过热休克蛋白 90 与 BCL6 形成复合物。

Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90.

机构信息

Department of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou, China.

Department of Medical Oncology, Institute of Clinical Science, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Cell Commun Signal. 2018 Aug 24;16(1):50. doi: 10.1186/s12964-018-0258-6.

DOI:10.1186/s12964-018-0258-6
PMID:30143009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6108153/
Abstract

BACKGROUND

Wilms' tumor 1-associating protein (WTAP) is a nuclear protein, which is ubiquitously expressed in many tissues. Furthermore, in various types of malignancies WTAP is overexpressed and plays a role as an oncogene. The function of WTAP in diffuse large B-cell lymphoma (DLBCL), however, remains unclear.

METHODS

Immunohistochemistry was applied to evaluate the levels of WTAP expression in DLBCL tissues and normal lymphoid tissues. Overexpression and knock-down of WTAP in DLBCL cell lines, verified on mRNA and protein level served to analyze cell proliferation and apoptosis in DLBCL cell lines by flow cytometry. Finally, co-immunoprecipitation (Co-IP), IP, and GST-pull down assessed the interaction of WTAP with Heat shock protein 90 (Hsp90) and B-cell lymphoma 6 (BCL6) as well as determined the extend of its ubiquitinylation.

RESULTS

WTAP protein levels were consistently upregulated in DLBCL tissues. WTAP promoted DLBCL cell proliferation and improved the ability to confront apoptosis, while knockdown of WTAP in DLBCL cell lines allowed a significant higher apoptosis rate after treatment with Etoposide, an anti-tumor drug. The stable expression of WTAP was depended on Hsp90. In line, we demonstrated that WTAP could form a complex with BCL6 via Hsp90 in vivo and in vitro.

CONCLUSION

WTAP is highly expressed in DLBCL, promoting growth and anti-apoptosis in DLBCL cell lines. WTAP is a client protein of Hsp90 and can appear in a complex with BCL6 and Hsp90 in DLBCL. Down-regulation of WTAP could improve the chemotherapeutic treatments in DLBCL.

摘要

背景

Wilms 肿瘤 1 相关蛋白(WTAP)是一种核蛋白,在许多组织中广泛表达。此外,在各种类型的恶性肿瘤中,WTAP 过表达并发挥癌基因的作用。然而,WTAP 在弥漫性大 B 细胞淋巴瘤(DLBCL)中的功能尚不清楚。

方法

应用免疫组织化学方法评估 WTAP 在 DLBCL 组织和正常淋巴组织中的表达水平。通过流式细胞术分析 DLBCL 细胞系中 WTAP 的过表达和敲低对细胞增殖和凋亡的影响。最后,通过 co-immunoprecipitation(Co-IP)、IP 和 GST-pull down 评估 WTAP 与热休克蛋白 90(Hsp90)和 B 细胞淋巴瘤 6(BCL6)的相互作用以及其泛素化程度。

结果

WTAP 蛋白水平在 DLBCL 组织中持续上调。WTAP 促进 DLBCL 细胞增殖并提高细胞抗凋亡能力,而在 DLBCL 细胞系中敲低 WTAP 后,用抗肿瘤药物依托泊苷处理可显著提高细胞凋亡率。WTAP 的稳定表达依赖于 Hsp90。我们还证明了 WTAP 可以在体内和体外通过 Hsp90 与 BCL6 形成复合物。

结论

WTAP 在 DLBCL 中高表达,促进 DLBCL 细胞系的生长和抗凋亡。WTAP 是 Hsp90 的客户蛋白,可与 BCL6 和 Hsp90 形成复合物存在于 DLBCL 中。下调 WTAP 可改善 DLBCL 的化疗治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/270c054e22e8/12964_2018_258_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/0a5b8553e3cc/12964_2018_258_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/05f30d1db645/12964_2018_258_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/943e359a8bda/12964_2018_258_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/898239dd136d/12964_2018_258_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/270c054e22e8/12964_2018_258_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/0a5b8553e3cc/12964_2018_258_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/05f30d1db645/12964_2018_258_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/943e359a8bda/12964_2018_258_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/898239dd136d/12964_2018_258_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cf/6108153/270c054e22e8/12964_2018_258_Fig5_HTML.jpg

相似文献

1
Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90.Wilms 瘤 1 相关蛋白在弥漫性大 B 细胞淋巴瘤中发挥侵袭性作用,并通过热休克蛋白 90 与 BCL6 形成复合物。
Cell Commun Signal. 2018 Aug 24;16(1):50. doi: 10.1186/s12964-018-0258-6.
2
miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.微小RNA-10a通过靶向弥漫性大B细胞淋巴瘤中的BCL6来抑制细胞增殖并促进细胞凋亡。
Protein Cell. 2016 Dec;7(12):899-912. doi: 10.1007/s13238-016-0316-z. Epub 2016 Nov 4.
3
Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.肾母细胞瘤 1 相关蛋白通过调节 CDK2 mRNA 的稳定性促进肾细胞癌的增殖。
J Exp Clin Cancer Res. 2018 Feb 27;37(1):40. doi: 10.1186/s13046-018-0706-6.
4
MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type.MEF2B 是 BCL6 基因转录复合物的成员,并在生发中心 B 细胞样弥漫性大 B 细胞淋巴瘤中诱导其表达。
Lab Invest. 2019 Apr;99(4):539-550. doi: 10.1038/s41374-018-0152-2. Epub 2018 Nov 16.
5
The mA methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the mA modification of catenin beta 1.mA甲基转移酶WTAP通过调节连环蛋白β1的mA修饰在弥漫性大B细胞淋巴瘤的发展中起关键作用。
Ann Transl Med. 2022 Jul;10(14):779. doi: 10.21037/atm-22-3027.
6
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.BCL6通过不同的生化机制使淋巴瘤细胞得以存活和分化。
Blood. 2007 Sep 15;110(6):2067-74. doi: 10.1182/blood-2007-01-069575. Epub 2007 Jun 1.
7
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.FBXO11 靶向 BCL6 进行降解,在弥漫性大 B 细胞淋巴瘤中失活。
Nature. 2012 Jan 5;481(7379):90-3. doi: 10.1038/nature10688.
8
A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion.miR-144 在弥漫大 B 细胞淋巴瘤增殖和侵袭中的关键作用
Cancer Immunol Res. 2016 Apr;4(4):337-44. doi: 10.1158/2326-6066.CIR-15-0161. Epub 2016 Feb 9.
9
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.在人类弥漫性大B细胞淋巴瘤细胞中,BCL6对EP300的抑制作用为合理的联合治疗提供了基础。
J Clin Invest. 2010 Dec 1;120(12):4569-82. doi: 10.1172/JCI42869. Epub 2010 Nov 1.
10
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.合理设计的BCL6抑制剂靶向活化B细胞弥漫性大B细胞淋巴瘤。
J Clin Invest. 2016 Sep 1;126(9):3351-62. doi: 10.1172/JCI85795. Epub 2016 Aug 2.

引用本文的文献

1
WTAP Accelerates Exhaustion of CD8 T Cells and Progression of Hepatocellular Carcinoma by Promoting m6A Modification and Translation of PD1 mRNA.WTAP通过促进m6A修饰和PD1 mRNA的翻译加速CD8 T细胞耗竭和肝细胞癌进展。
Mediators Inflamm. 2025 Jun 18;2025:6217272. doi: 10.1155/mi/6217272. eCollection 2025.
2
WTAP-induced mA Methylation of Atoh8 Promotes Cell Proliferation and Fibrosis in Diabetic Nephropathy.WTAP诱导的Atoh8基因甲基化促进糖尿病肾病中的细胞增殖和纤维化
Cell Biochem Biophys. 2025 May 22. doi: 10.1007/s12013-025-01778-3.
3
WTAP-Mediated N6-Methyladenosine Modification Promotes Gastric Cancer Progression by Regulating MAP2K6 Expression.

本文引用的文献

1
Interactions, localization, and phosphorylation of the mA generating METTL3-METTL14-WTAP complex.mA 生成 METTL3-METTL14-WTAP 复合物的相互作用、定位和磷酸化。
RNA. 2018 Apr;24(4):499-512. doi: 10.1261/rna.064063.117. Epub 2018 Jan 18.
2
The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target.BCL6癌蛋白作为癌症治疗靶点的作用不断扩展。
Clin Cancer Res. 2017 Feb 15;23(4):885-893. doi: 10.1158/1078-0432.CCR-16-2071. Epub 2016 Nov 23.
3
The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma.
WTAP介导的N6-甲基腺苷修饰通过调控MAP2K6表达促进胃癌进展。
J Cancer. 2025 Jan 27;16(5):1420-1437. doi: 10.7150/jca.98559. eCollection 2025.
4
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond.PU-H71(NSC 750424):一种靶向癌症及其他领域中热休克蛋白90(HSP90)的分子杰作。
Front Pharmacol. 2024 Nov 5;15:1475998. doi: 10.3389/fphar.2024.1475998. eCollection 2024.
5
N-methyladenosine and its epitranscriptomic effects on hematopoietic stem cell regulation and leukemogenesis.N6-甲基腺苷及其对造血干细胞调控和白血病发生的表观转录组学效应。
Mol Med. 2024 Nov 4;30(1):196. doi: 10.1186/s10020-024-00965-x.
6
RNA modification in normal hematopoiesis and hematologic malignancies.正常造血和血液系统恶性肿瘤中的RNA修饰
MedComm (2020). 2024 Oct 23;5(11):e787. doi: 10.1002/mco2.787. eCollection 2024 Nov.
7
Ramifications of m6A Modification on ncRNAs in Cancer.m6A修饰对癌症中非编码RNA的影响
Curr Genomics. 2024 May 31;25(3):158-170. doi: 10.2174/0113892029296712240405053201. Epub 2024 Apr 9.
8
WTAP participates in neuronal damage by protein translation of NLRP3 in an m6A-YTHDF1-dependent manner after traumatic brain injury.WTAP 通过 m6A-YTHDF1 依赖性方式参与创伤性脑损伤后 NLRP3 的蛋白翻译,导致神经元损伤。
Int J Surg. 2024 Sep 1;110(9):5396-5408. doi: 10.1097/JS9.0000000000001794.
9
A new perspective on hematological malignancies: m6A modification in immune microenvironment.血液系统恶性肿瘤的新视角:免疫微环境中的m6A修饰
Front Immunol. 2024 May 28;15:1374390. doi: 10.3389/fimmu.2024.1374390. eCollection 2024.
10
WTAP promotes proliferation of esophageal squamous cell carcinoma via mA-dependent epigenetic promoting of PTP4A1.WTAP 通过 mA 依赖性表观遗传促进 PTP4A1 促进食管鳞状细胞癌的增殖。
Cancer Sci. 2024 Jul;115(7):2254-2268. doi: 10.1111/cas.15924. Epub 2024 May 15.
LITAF与BCL6的反馈回路参与调节B细胞非霍奇金淋巴瘤中的细胞凋亡。
Oncotarget. 2016 Nov 22;7(47):77444-77456. doi: 10.18632/oncotarget.12680.
4
IFITM1 promotes the metastasis of human colorectal cancer via CAV-1.干扰素诱导跨膜蛋白1通过小窝蛋白-1促进人结直肠癌转移。
Cancer Lett. 2015 Nov 1;368(1):135-143. doi: 10.1016/j.canlet.2015.07.034. Epub 2015 Aug 7.
5
Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis.碳酸酐酶IV通过靶向WTAP-WT1-TBL1轴抑制Wnt信号通路,从而抑制结肠癌的发展。
Gut. 2016 Sep;65(9):1482-93. doi: 10.1136/gutjnl-2014-308614. Epub 2015 Jun 12.
6
Loss of B-cell receptor expression defines a subset of diffuse large B-cell lymphoma characterized by silent BCR/PI3K/AKT signaling and a germinal center phenotype displaying low-risk clinicopathologic features.B细胞受体表达缺失定义了弥漫性大B细胞淋巴瘤的一个亚组,其特征为沉默的BCR/PI3K/AKT信号传导以及显示低风险临床病理特征的生发中心表型。
Am J Surg Pathol. 2015 Jul;39(7):902-11. doi: 10.1097/PAS.0000000000000396.
7
Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites.m6A 甲基化酶的扰动揭示了内部位点和 5' 位点上两种不同类型的 mRNA 甲基化。
Cell Rep. 2014 Jul 10;8(1):284-96. doi: 10.1016/j.celrep.2014.05.048. Epub 2014 Jun 26.
8
WTAP is a novel oncogenic protein in acute myeloid leukemia.WTAP是急性髓系白血病中的一种新型致癌蛋白。
Leukemia. 2014 May;28(5):1171-4. doi: 10.1038/leu.2014.16. Epub 2014 Jan 13.
9
Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase.哺乳动物 WTAP 是 RNA N6-甲基腺嘌呤甲基转移酶的调节亚基。
Cell Res. 2014 Feb;24(2):177-89. doi: 10.1038/cr.2014.3. Epub 2014 Jan 10.
10
WT1 overexpression affecting clinical outcome in non-hodgkin lymphomas and adult acute lymphoblastic leukemia.WT1过表达影响非霍奇金淋巴瘤和成人急性淋巴细胞白血病的临床结局。
Pathol Oncol Res. 2014 Jul;20(3):565-70. doi: 10.1007/s12253-013-9729-7. Epub 2013 Dec 28.